Arab Canada News

News

Respiratory Syncytial Virus - Frequently Asked Questions

Respiratory Syncytial Virus - Frequently Asked Questions

By م.زهير الشاعر

Published: December 28, 2024

Respiratory syncytial virus (RSV) vaccines are currently available in Canada — and it's natural to have any questions you may have.

The doctors at +VaxFacts Clinic are here to answer all your inquiries.

What is respiratory syncytial virus?

Respiratory syncytial virus (RSV) is a common respiratory virus that can become serious for certain groups. Its symptoms resemble those of a cold or flu and include coughing, runny nose, fever, and wheezing during breathing. In severe cases, RSV can cause serious chest infections such as bronchitis or pneumonia, which may require hospitalization, especially in cases of:

• ​Infants, particularly those under six months of age.

• ​Seniors aged 60 and older.

• ​Those with underlying health issues.

How does respiratory syncytial virus spread?

RSV spreads through direct contact with infected individuals or surfaces and through droplets from coughs and sneezes. The virus is highly contagious and spreads more in places frequented by young children.

What are the options for protecting infants from respiratory syncytial virus?

1. Preventive antibody <>:

-​ The Beyfortus injection is an antibody administered to infants once to protect them from respiratory syncytial virus for up to six months

-​It is recommended to give the vaccine, which is covered for the following:

o Infants born during the respiratory syncytial virus season (November 2024 – March 2025)

o Infants born in 2024 before the respiratory syncytial virus season

o Infants with high-risk conditions up to 24 months of age who will experience the second season of respiratory syncytial virus

2. Maternal respiratory syncytial virus vaccine <>:

- ​Given to pregnant women between weeks 32-36 of pregnancy

- ​The mother's body produces antibodies and transfers them to the child, protecting them during the first six months of life

We recommend administering the Beyfortus injection for infants as it has proven to be more effective (about 80% against severe RSV infection) compared to giving the vaccine to mothers.

Is the Beyfortus vaccine safe for infants and young children?

Yes, Health Canada has approved the Beyfortus injection for its efficacy and safety. Common side effects include mild swelling or pain at the injection site and fever, while serious side effects are rare.

Where can infants receive protection against respiratory syncytial virus?

The Beyfortus injection is often given in the hospital after birth or at primary healthcare clinics and public health units.

Which groups of seniors and high-risk individuals are eligible to receive the respiratory syncytial virus vaccine?

In Ontario, the respiratory syncytial virus vaccine is publicly funded for individuals aged 60 and older whose condition is classified as high risk, including:

- ​Residents of long-term care homes or retirement homes

- ​Patients undergoing dialysis or who have received organ or stem cell transplants

- ​Homeless individuals

- ​Those identified as individuals from Indigenous groups known as (First Nations) or (Inuit) or (Métis)

Others may receive the respiratory syncytial virus vaccine by purchasing it privately, which is sometimes covered by insurance.

What are the options for seniors to be vaccinated against respiratory syncytial virus?

1. Vaccine <>: This is a booster vaccine designed to protect seniors from acute respiratory syncytial virus.

2. Vaccine <>: This is a bivalent compound vaccine that is also effective in preventing lower respiratory tract diseases associated with respiratory syncytial virus.

Can the respiratory syncytial virus vaccine be received alongside other vaccines?

Yes, it is safe and even recommended to receive the respiratory syncytial virus vaccine at the same time as other seasonal vaccines, such as flu and COVID-19 vaccines, to enhance protection during the respiratory illness season.

Are respiratory syncytial virus vaccines safe for seniors?

Both the Arexvy and Abrysvo vaccines for respiratory syncytial virus are safe, and recipients tolerate them well. Common side effects include mild pain at the injection site, fatigue, and headache.

How can I book an appointment to speak via phone with a doctor at +VaxFacts Clinic?

If you have any questions or concerns, or if you would like further clarification by speaking directly with a doctor confidentially and without judgment, please book an appointment through the website www.shn.ca/VaxFacts.

 

 

Comments

Related

Weather

Today

Saturday, 05 July 2025

Loading...
icon --°C

--°C

--°C

  • --%
  • -- kmh
  • --%